Cargando…

Improvement of survival for non-small cell lung cancer over time

Non-small cell lung cancer (NSCLC) is the main histological subtype of lung cancer, which is the leading cause of cancer death. It is unclear whether the improved survival seen at high-volume centers applies to the general population and, more importantly, whether the improvement in lung cancer surv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Wenjie, Yu, Xinnian, Mao, Qixing, Xia, Wenying, Wang, Anpeng, Dong, Gaochao, Chen, Bing, Ma, Weidong, Xu, Lin, Jiang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587133/ https://www.ncbi.nlm.nih.gov/pubmed/28919778 http://dx.doi.org/10.2147/OTT.S145036

Ejemplares similares

Young age increases risk for lymph node positivity but decreases risk for non-small cell lung cancer death
por: Xia, Wenjie, et al.
Publicado: (2018)

Microarray analyses reveal genes related to progression and prognosis of esophageal squamous cell carcinoma
por: Qixing, Mao, et al.
Publicado: (2017)

Integrative analysis of differential genes and identification of a “2‐gene score” associated with survival in esophageal squamous cell carcinoma
por: Wang, Lin, et al.
Publicado: (2018)

Effect of lymph node examined count on accurate staging and survival of resected esophageal cancer
por: Xia, Wenjie, et al.
Publicado: (2019)

A network-based signature to predict the survival of non-smoking lung adenocarcinoma
por: Mao, Qixing, et al.
Publicado: (2018)

Gut Microbiota Shapes the Efficiency of Cancer Therapy
por: Ma, Weidong, et al.
Publicado: (2019)

The TWIST1-centered competing endogenous RNA network promotes proliferation, invasion, and migration of lung adenocarcinoma
por: Xia, Wenjie, et al.
Publicado: (2019)

The Long Noncoding RNA LINC00665 Facilitates c-Myc Transcriptional Activity via the miR-195-5p MYCBP Axis to Promote Progression of Lung Adenocarcinoma
por: Wang, Anpeng, et al.
Publicado: (2021)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma
por: Feng, Yipeng, et al.
Publicado: (2023)

Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway
por: Zhang, Te, et al.
Publicado: (2022)

Aberrant super-enhancer landscape reveals core transcriptional regulatory circuitry in lung adenocarcinoma
por: Zhang, Te, et al.
Publicado: (2020)

Circular RNA circCRIM1 inhibits invasion and metastasis in lung adenocarcinoma through the microRNA (miR)‐182/miR‐93‐leukemia inhibitory factor receptor pathway
por: Wang, Lin, et al.
Publicado: (2019)

Clinical and prognostic implications of an immune‐related risk model based on TP53 status in lung adenocarcinoma
por: Song, Xuming, et al.
Publicado: (2021)

Different associations between organ-specific immune-related adverse event and survival in non-small cell lung cancer patients treated with programmed death-1 inhibitors-based combination therapy
por: Chen, Yuzhong, et al.
Publicado: (2023)

CT-Based Deep Learning Model for Invasiveness Classification and Micropapillary Pattern Prediction Within Lung Adenocarcinoma
por: Ding, Hanlin, et al.
Publicado: (2020)

circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression
por: Liang, Yingkuan, et al.
Publicado: (2020)

Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy
por: Yin, Xuewen, et al.
Publicado: (2023)

PKM2 and cancer: The function of PKM2 beyond glycolysis
por: DONG, GAOCHAO, et al.
Publicado: (2016)

DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma
por: Xia, Wenjie, et al.
Publicado: (2015)

Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis
por: Qixing, Mao, et al.
Publicado: (2015)

CircIMMP2L promotes esophageal squamous cell carcinoma malignant progression via CtBP1 nuclear retention dependent epigenetic modification
por: Liang, Yingkuan, et al.
Publicado: (2021)

A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

Non-genetic stratification reveals epigenetic heterogeneity and identifies vulnerabilities of glycolysis addiction in lung adenocarcinoma subtype
por: Song, Xuming, et al.
Publicado: (2022)

Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels
por: Dong, Gaochao, et al.
Publicado: (2016)

KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer
por: Wu, Yaqin, et al.
Publicado: (2018)

CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies
por: Mao, Qixing, et al.
Publicado: (2015)

Integrative analysis of copy number and transcriptional expression profiles in esophageal cancer to identify a novel driver gene for therapy
por: Dong, Gaochao, et al.
Publicado: (2017)

Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a
por: Wang, Siwei, et al.
Publicado: (2016)

Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma
por: Li, Rutao, et al.
Publicado: (2022)

Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma
por: Liang, Yingkuan, et al.
Publicado: (2020)

High‑risk pathological subtype associated FAM83A‑AS1 promotes malignancy and glycolysis of lung adenocarcinoma via miR‑202‑3p/HK2 axis
por: Xiong, Xinkui, et al.
Publicado: (2023)

Survival from alcoholic hepatitis has not improved over time
por: Hughes, Emily, et al.
Publicado: (2018)

Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
por: Khakwani, A, et al.
Publicado: (2013)

The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer
por: Xia, Bing, et al.
Publicado: (2011)

Improving lung cancer survival; time to move on
por: Heuvers, Marlies E, et al.
Publicado: (2012)

Correction: Survival from alcoholic hepatitis has not improved over time
por: Hughes, Emily, et al.
Publicado: (2018)

Increased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review
por: Zhu, Lucheng, et al.
Publicado: (2016)

Lobectomy Can Improve the Survival of Patients With Non-small Cell Lung Cancer With Lung Oligometastatic
por: Wang, Lingwei, et al.
Publicado: (2021)

Improvement of Survival Over Time for Colon Cancer Patients by Anatomical Sub‐sites
por: Kawazuma, Yoshikazu, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_vbqquitvoatnhb8pmd146tr7vl